What does this source bring?
After discontinuation of atropine in ATOM2, rebound dependent on the previous concentration was observed.
The post-treatment phase concerns participants in a specific study. It does not designate a universal withdrawal pattern.
CLAIM-ATOM-STOPScope of testing and verification
- The role of the record
- Source of the claim
- Population
- ATOM2 participants after withdrawal
- N
- Not applicable / not determined within the verified range
- Geography
- Singapore
- Observation (months)
- 12
- Comparator
- Not applicable / no common comparator
- Result
- After discontinuation of atropine in ATOM2, rebound dependent on the previous concentration was observed.
- Safety
- This record does not allow estimation of the frequency of rare adverse events.
- Device/structure
- Not applicable / not determined within the verified range
- Publisher of the publication
- Elsevier BV
- Financing
- Not determined within the proven range; see the declaration in full text.
- Conflicts of interest
- Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
- DOI
- 10.1016 /j.ajo. 2013.09.020
- PMID
- 24315293
- What was checked
- Bibliographic metadata and abstract in Europe PMC / PubMed; Crossref metadata
- Date of verification
- 2026-09-09
This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.